Editorial Revisado por pares

Redox Regulation of NF-κB: From Basic to Clinical Research

2009; Mary Ann Liebert, Inc.; Volume: 11; Issue: 9 Linguagem: Inglês

10.1089/ars.2009.2659

ISSN

1557-7716

Autores

Fernando Antunes, Derick Han,

Tópico(s)

Chemotherapy-induced organ toxicity mitigation

Resumo

Antioxidants & Redox SignalingVol. 11, No. 9 Forum EditorialRedox Regulation of NF-κB: From Basic to Clinical ResearchFernando Antunes and Derick HanFernando AntunesDepartamento de Química e Bioquímica da Faculdade de Ciências da Universidade de Lisboa, Lisboa, Portugal.Grupo de Bioquímica dos Oxidantes e Antioxidantes, Centro de Química e Bioquímica, P-1749-016 Lisboa, Portugal.Instituto de Investigação Científica Bento da Rocha Cabral, Lisboa, Portugal.Search for more papers by this author and Derick HanResearch Center for Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California.Search for more papers by this authorPublished Online:10 Aug 2009https://doi.org/10.1089/ars.2009.2659AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Redox Regulation of NF-κB: From Basic to Clinical Research." , 11(9), pp. 2055–2056FiguresReferencesRelatedDetailsCited byExploring the cardioprotective effects of canagliflozin against cisplatin‐induced cardiotoxicity: Role of iNOS/NF‐κB, Nrf2, and Bax/cytochrome C/Bcl‐2 signals16 January 2023 | Journal of Biochemical and Molecular Toxicology, Vol. 37, No. 4Redox signaling in diabetic retinopathy and opportunity for therapeutic intervention through natural productsEuropean Journal of Medicinal Chemistry, Vol. 244Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease18 December 2020 | Nutrition Reviews, Vol. 79, No. 11Asperuloside suppressing oxidative stress and inflammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2/HO-1 and NF-κB pathwaysChemico-Biological Interactions, Vol. 344Redox Potential of Antioxidants in Cancer Progression and Prevention20 November 2020 | Antioxidants, Vol. 9, No. 11Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatmentMechanisms of Ageing and Development, Vol. 186GPR174 suppression attenuates retinopathy in angiotensin II (Ang II)-treated mice by reducing inflammation via PI3K/AKT signalingBiomedicine & Pharmacotherapy, Vol. 122CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activationRedox Biology, Vol. 26Nonpharmacologic Strategies to Modulate Nuclear Factor Erythroid 2–related Factor 2 Pathway in Chronic Kidney DiseaseJournal of Renal Nutrition, Vol. 27, No. 4Activation of Nrf2-Antioxidant Signaling by 1,25-Dihydroxycholecalciferol Prevents Leptin-Induced Oxidative Stress and Inflammation in Human Endothelial CellsThe Journal of Nutrition, Vol. 147, No. 4Brazil nut consumption modulates Nrf2 expression in hemodialysis patients: A pilot study14 April 2016 | Molecular Nutrition & Food Research, Vol. 60, No. 7Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and TherapyOxidative Medicine and Cellular Longevity, Vol. 2016NRF2 and NF-κB mRNA expression in chronic kidney disease: a focus on nondialysis patients22 October 2015 | International Urology and Nephrology, Vol. 47, No. 12Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf214 January 2015 | Journal of Nephrology, Vol. 28, No. 4Plant-Derived PolyphenolsAdipokines in obesityClinica Chimica Acta, Vol. 419Nrf2–keap1 system versus NF-κB: The good and the evil in chronic kidney disease?Biochimie, Vol. 94, No. 12Keap1: One stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xLCancer Letters, Vol. 325, No. 1Mycoepoxydiene, a fungal polyketide inhibits MCF-7 cells through simultaneously targeting p53 and NF-κB pathwaysBiochemical Pharmacology, Vol. 84, No. 7 Volume 11Issue 9Sep 2009 InformationCopyright 2009, Mary Ann Liebert, Inc.To cite this article:Fernando Antunes and Derick Han.Redox Regulation of NF-κB: From Basic to Clinical Research.Antioxidants & Redox Signaling.Sep 2009.2055-2056.http://doi.org/10.1089/ars.2009.2659Published in Volume: 11 Issue 9: August 10, 2009Online Ahead of Print:July 22, 2009Online Ahead of Editing: May 13, 2009PDF download

Referência(s)